miRNA in Fetal Overgrowth

NCT01935076 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2014-05-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether placental and umbilical cord blood miRNA expression is altered in women with obesity with macrosomic neonates to when compared to miRNA expression from control patients.

Conditions

Interventions

BEHAVIORAL

Neonatal exposure to maternal obesity

Sponsors & Collaborators

Principal Investigators

  • Celeste P Durnwald, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01935076 on ClinicalTrials.gov